Bioethics News

Risky Treatment Can Stop Multiple Sclerosis for Years

February 21, 2017

(BBC) – A multiple sclerosis treatment being tested in patients can stop the disease for at least five years, say doctors. The risky therapy involves wiping out the person’s immune system with strong cancer drugs and then rebooting it with a stem cell transplant. Doctors say only some patients will be suitable to try it, particularly because it is so high risk. Out of 281 people who had the treatment, nearly half benefited, but eight died shortly afterwards.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.